A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
about
Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysisPolyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescentsMercury exposure, nutritional deficiencies and metabolic disruptions may affect learning in childrenOmega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?Critical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatmentSupplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature DataMaternal Malnutrition in the Etiopathogenesis of Psychiatric Diseases: Role of Polyunsaturated Fatty AcidsNatural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination TherapyOmega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviorsN-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for PsychopathologyOmega-3 polyunsaturated fatty acid supplementation and cognition: A systematic review and meta-analysisSupplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems - an observational cohort study.Essential fatty acids and the brain.Effects of omega 3 fatty acids supplementation in behavior and non-neurodegenerative neuropsychiatric disorders.Omega-3 fatty acids in ADHD and related neurodevelopmental disorders.'Junk food' diet and childhood behavioural problems: results from the ALSPAC cohort.Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan.Effects of an open-label pilot study with high-dose EPA/DHA concentrates on plasma phospholipids and behavior in children with attention deficit hyperactivity disorder.Biochemical and Psychological Effects of Omega-3/6 Supplements in Male Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Clinical Trial.Fatty acid status and behavioural symptoms of attention deficit hyperactivity disorder in adolescents: a case-control study.Current clinical applications of omega-6 and omega-3 fatty acids.The role of dietary fatty acids in children's behaviour and learning.(N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders.Complementary and alternative therapies for pediatric attention deficit hyperactivity disorder: a descriptive review.A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 yearNutritional properties of dietary omega-3-enriched phospholipids.Docosahexaenoic acid and cognitive function: Is the link mediated by the autonomic nervous system?A systematic review of the effect of dietary exposure that could be achieved through normal dietary intake on learning and performance of school-aged children of relevance to UK schools.Omega-3 fatty acid treatment of children with attention-deficit hyperactivity disorder: A randomized, double-blind, placebo-controlled studyRole of docosahexaenoic acid in maternal and child mental health.Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials.Effect of Poly Unsaturated Fatty Acids Administration on Children with Attention Deficit Hyperactivity Disorder: A Randomized Controlled Trial.Does omega-3 supplement enhance the therapeutic results of methylphenidate in attention deficit hyperactivity disorder patients?Nutrient supplementation approaches in the treatment of ADHD.Dietary intake of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in children - a workshop report.The impact of polyunsaturated fatty acids in reducing child attention deficit and hyperactivity disorders.The use of omega-3 fatty acids in mental illness.Influences of micronutrient and omega-3 fatty acid supplementation on cognition, learning, and behavior: methodological considerations and implications for children and adolescents in developed societies.Effects of low doses of polyunsaturated Fatty acids on the attention deficit/hyperactivity disorder of children: a systematic reviewResearch review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies.
P2860
Q22252430-4F7E92F6-A1A0-4048-A713-A9DCB8741E8DQ24202221-7DD96A66-ADE4-4CD1-A353-07404748FE8CQ24644491-AB2C49DA-4709-46F2-ACC0-67C0749F10C6Q24681087-B484FC53-B579-4BA8-9F2D-536293454796Q26739640-D3382D8C-A522-453E-8A0A-FEB0CBCF1386Q26740508-37183357-33A5-4849-88D0-0A7C8B8C6BE4Q26740518-82CC6B11-1FEC-4A3B-ABAC-C5E1AEE063B8Q26766330-F968D7CB-32DB-42C9-9C29-FECE31085F18Q26822591-704B9875-4DB2-445F-ABE2-1E329BB098EBQ28072641-AF976CC4-856D-4061-B9F8-7BA6749A172FQ28315392-60858AEC-CBC3-47E9-B696-57D115ED4E9FQ34139903-142A4C5C-4E3C-4F1B-BBF4-0875D5689E31Q34194497-66E044DD-2AFC-40F9-B8C2-9FA06B9B4C41Q34275382-0CB948AC-7DFD-4F4A-868C-0A5605F2F390Q34538615-098F7243-78A3-493D-8457-5A367E7642B1Q34722050-76B0B6F0-C082-468F-BFE0-3710297F48A0Q35670890-0702E40C-CFA4-48DC-AF6F-C6589D04D439Q35981290-400731E9-2C45-4096-B8AB-413CE856F6C3Q36405752-37E116F7-A632-4DC4-A621-9902698FFD8CQ36510618-C23FA8D8-EF25-4770-B77B-0BC8E9422440Q36548128-CD7F1218-1856-483B-AFFE-91C5F03A5155Q36688744-6BD105E5-8277-441C-9233-1C32ECE2047AQ36830364-A38FDF57-0E8A-49DD-B715-3E62E45186B3Q36900107-72F4B1DC-B78D-4942-B368-DB6DD1A990BBQ37053396-22A60833-4FE4-4EDE-A73C-88103F027591Q37105403-84DF83AC-7E00-415A-8FDA-E588E57B1746Q37115632-2263CDEF-88AE-41AE-9839-1B796AD28FBBQ37123638-7E4EB8A2-ACF9-437E-AC84-63257240F4A8Q37141442-8F90DB30-29C1-4A2B-A191-114F59D5A76EQ37155207-E1749237-9C3A-43D4-B739-3A14C387C5BDQ37349962-501D4B25-D36E-4181-9BC8-BC9E7EF13851Q37353046-4B730A88-C3AE-4F2A-8BC6-0408C7AA7711Q37413774-3CF4A3FF-D3ED-4F64-89EE-FA99580576A8Q37432176-13518086-BD2C-40B5-A9B4-67399D4F811FQ37699445-3AECD29F-3D6F-43AD-8DD0-C647AC737BA0Q37737857-05DC2165-A566-435A-8904-2BD847F43FCDQ37937303-E18EBBC2-D4E7-46B2-AAFD-82D5AE671868Q38049343-428EB336-2F9E-4AF3-805A-F47DE5E67720Q38133553-FC7B3D27-067E-49B5-9C5D-B0B2C04F0ADEQ38189499-1337FD81-D93D-45A0-95EE-E6D171F90AE4
P2860
A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A randomized, double-blind, pl ...... eficit/hyperactivity disorder.
@en
A randomized, double-blind, pl ...... eficit/hyperactivity disorder.
@nl
type
label
A randomized, double-blind, pl ...... eficit/hyperactivity disorder.
@en
A randomized, double-blind, pl ...... eficit/hyperactivity disorder.
@nl
prefLabel
A randomized, double-blind, pl ...... eficit/hyperactivity disorder.
@en
A randomized, double-blind, pl ...... eficit/hyperactivity disorder.
@nl
P2093
P921
P356
P1476
A randomized, double-blind, pl ...... eficit/hyperactivity disorder.
@en
P2093
P304
P356
10.1067/MPD.2001.116050
P407
P577
2001-08-01T00:00:00Z